A primary illness that accounts for a significant portion of fatalities worldwide is cancer.
Among the main malignancies, lung cancer is recognised as the most chronic kind of cancer …

Lung cancer (LC) is one of the leading causes of mortality accounting for almost 25% of
cancer deaths throughout the world. The shortfall of affordable and effective first-line …

Background Chemodynamic therapy (CDT) relying on intracellular iron ions and H2O2 is a
promising therapeutic strategy due to its tumor selectivity, which is limited by the not enough …

Infiltration of tumor‐associated macrophages (TAM) characterized by an M2 phenotype is an
overriding feature in malignant tumors. Reprogramming TAM is the most cutting‐edge …

Ciprofloxacin (CIP), a potent anti-bacterial agent of the fluroquinolone family, shows poor
solubility and permeability, thus leading to the development of intracellular pathogens …

Lung cancer recruits tumor-associated macrophages (TAMs) massively, whose
predominantly pro-tumor M2 phenotype leads to immunosuppression. Dihydroartemisinin …

Annexin V and propidium iodide staining is widely used for determining the cellular death
through apoptosis. In the presence of Ca 2+ ions, annexin V has a strong binding affinity for …

Lung cancer is the leading cause of cancer‐related mortality both in men and women and
accounts for 18.4% of all cancer‐related deaths. Although advanced therapy methods have …

Cancer is a chronic disease that is responsible for the high death rate, globally. The
administration of anticancer drugs is one crucial approach that is employed for the treatment …

Abstract Dihydroartemisinin (DHA), a first-line antimalarial drug, has demonstrated great
anticancer effects in many types of tumors, including liver cancer, glioblastoma, and …